OncoPep, Inc.
生物技术研究
Boston，Massachusetts 777 位关注者
To develop and commercialize targeted immuno-therapeutics which prevent the progression of cancer and prolong survival.
关于我们
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
- 网站
-
http://oncopep.com
OncoPep, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
- 领域
- Oncology、T Cell、Immunotherapeutics和Biotechnolgy
地点
-
主要
获取路线
US，Massachusetts，Boston，02215